Actively Recruiting

Early Phase 1
Age: 18Years - 85Years
MALE
NCT07245628

A Trial of Self-Adjusted Nitrous Versus Placebo During Office Vasectomy

Led by Alexandra J. Berger Eberhardt, MD · Updated on 2025-11-24

50

Participants Needed

1

Research Sites

236 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to see if nitrous oxide is safe and effective to use during during vasectomies performed in a clinic/in-office setting. This trial will compare self-administered nitrous oxide versus a placebo (oxygen) during office vasectomy. The main questions it aims to answer are: * Whether self-administered low dose (20-45%) nitrous oxide (SANO) reduces intraoperative anxiety and catastrophizing during office vasectomy. * To examine whether SANO reduces intraoperative pain or alters procedure duration, the rate of adverse events, or urologists' perception of ease and patient tolerance of the procedure. Participants will be asked to complete multiple surveys pre-procedure, intra-procedure, and post-procedure.

CONDITIONS

Official Title

A Trial of Self-Adjusted Nitrous Versus Placebo During Office Vasectomy

Who Can Participate

Age: 18Years - 85Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 - 85 at the time of screening
  • Desiring vasectomy for family planning purposes
  • Able to understand and complete patient questionnaires
  • Willing and able to provide written consent to participate in the study
Not Eligible

You will not qualify if you...

  • Patients with unilateral absence of the vas deferens
  • Patients who are deemed by study surgeons to have anatomy no amendable for office procedure
  • Patients who decline office vasectomy and request monitored anesthesia care
  • Patients taking benzodiazepine or narcotic medication daily or within 24 hours of the procedure
  • Patients with contraindications to nitrous oxide including:
  • Inner ear, bariatric, or eye surgery within the past 2 weeks
  • Current emphysematous blebs
  • Severe B-12 deficiency
  • History of bleomycin chemotherapy within the last year
  • Class III or higher heart failure

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here